ArticleJournal of enzyme inhibition and medicinal chemistry2023

Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents.

Sudong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.